Jon Cuthbert

The Bank of Korea has launched phase two of its digital won pilot, expanding to nine commercial banks to test deposit tokens for nationwide payments and government subsidies.

Nexalis Therapeutics (ASX:NX1) has commenced dosing in its Phase 1 clinical trial of IRX-616a.

Anax Metals (ASX:ANX) has secured commitments to raise approximately $10 million through a two-tranche placement.

Nvidia (NASDAQ:NVDA) has begun restarting its manufacturing lines for H200 processors destined for the Chinese market, according to CEO Jensen Huang.

Dogwood Therapeutics (NASDAQ:DWTX) reported its fourth-quarter and full-year 2025 financial results, highlighting a pivot toward late-stage clinical development for its lead analgesic candidate, Halneuron®.

Spire Global (NYSE:SPIR) reported fourth-quarter 2025 financial results characterized by a dramatic reduction in net loss and strong organic growth within its core data and space services segments.

Biotech royalty aggregator XOMA Royalty 9NASDAQ:XOMA) reported a sharp financial turnaround for its 2025 fiscal year, swinging to a robust profit on the back of surging revenues and executing multiple shareholder-value initiatives.

Hello Group (NASDAQ:MOMO) reported unaudited financial results for the fourth quarter and full year ended December 31, 2025, revealing a strategic pivot toward global markets.

Citigroup has reduced its 12-month price targets for Bitcoin and Ethereum, citing delays in US crypto regulation and broader macro uncertainty.

Tether has launched a new AI training framework under its QVAC platform, enabling large language models to be fine-tuned on consumer hardware including smartphones and non-Nvidia GPUs.